Oral herpes review separates symptom relief from recurrence prevention
An abstract-based summary describes different treatment goals, but provides no numerical benefit estimates or direct comparisons between individual options.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The review reports that treatments applied to lesions can shorten episodes and ease local symptoms when used early, but generally do not change how often episodes return. Medicines acting throughout the body were described as addressing both healing and recurrence prevention. The abstract offers broad treatment roles, without enough detail to rank individual options.
The abstract omits study counts, participant details, follow-up times and adverse-effect results. Missing study-level findings, numerical estimates and certainty assessments limit comparisons of benefits and harms.
Where the evidence comes from
The review includes randomized trials and observational studies. It explicitly cites randomized trials for treatment of individual episodes and ongoing suppression with systemic antivirals, but does not provide study-level results, numerical estimates or certainty assessments.
Emerging approaches remain uncertain
The authors discuss new formulations and delivery methods as possibilities for improving local treatment. Approaches aimed at the virus's dormant state or immune responses remain emerging directions; the abstract gives no results establishing lasting suppression.
The original publication
Topical and Systemic Therapeutic Approaches in the Treatment of Oral Herpes Simplex Virus Infection: A Systematic Review.
Mancini A, Inchingolo AM, Marinelli G et al.
Int J Mol Sci · 2025
- PubMed ID
- 40943411
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.